NCT02352389 A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents Status COMPLETED Phase N/A
NCT02336282 Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT02327845 Phenotype, Genotype & Biomarkers in ALS and Related Disorders Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02301065 Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors Status COMPLETED Phase N/A
NCT02270788 Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02261480 A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease Status COMPLETED Phase N/A
NCT02259348 Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Status TERMINATED Phase PHASE2
NCT02256137 A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02241005 Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci Status COMPLETED Phase NA
NCT02227472 Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease Status COMPLETED Phase N/A
NCT02212561 Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT02206906 Incentives to Promote Medication Adherence Among HIV-Infected Youth Status COMPLETED Phase N/A
NCT02199041 Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen Status TERMINATED Phase PHASE2
NCT02193724 Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma Status COMPLETED Phase N/A
NCT02159443 Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody Status COMPLETED Phase N/A